Indapta Therapeutics logo

Indapta Therapeutics

A biotechnology company focused on developing a natural killer cell therapy with potent ADCC activity to treat cancer.

14 employees · est. 2017 · United States

VS
Innate Pharma logo

Innate Pharma

196 employees · est. 1999 · Marseille, France

Innate Pharma is the older company (2017 vs 1999); Innate Pharma is the larger of the two.

Side-by-Side Comparison

Indapta Therapeutics Innate Pharma
Founded
2017 1999 older
Headquarters
United States Marseille, France
Employees
14 196 larger
Industry
Biopharma, Biotechnology Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Unknown Post Ipo Secondary
Total Funding
$77.00M $276.10M
Funding Rounds
8 8
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Cancer Therapy, Natural Killer Cells, ADCC Activity, Allogeneic Therapy, Monoclonal Antibodies, ADCs, Innate Immune Cell Engagers, Blood Cancer, Solid Tumor Cancer, Cell Therapy, Immuno-oncology, G-NK Cells, Therapeutic Antibodies, Biopharmaceuticals Biotech Company, Oncology-focused, Therapeutic Antibodies, Immune System, Cancer Treatment, NK Cell Biology, Tumor Microenvironment, Antibody Engineering, Global Presence, Euronext Paris, Nasdaq, Clinical-stage, Immunotherapy, Pipeline Of Antibodies, Strategic Alliances
Website
indapta.com innate-pharma.com
Indapta Therapeutics logo

About Indapta Therapeutics

Indapta Therapeutics is a biotechnology company founded in 2017, headquartered in the United States, and positioned at the forefront of developing a natural killer cell therapy with potent ADCC activity to combat cancer. Their allogeneic g-NK cells, known for their highly potent ADCC activity, are s...

Innate Pharma logo

About Innate Pharma

Innate Pharma is a global, clinical-stage oncology-focused biotech company founded in 1999 and headquartered in France. The company is dedicated to improving treatment and clinical outcomes for cancer patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Phar...

We will tell you when either one moves

BounceWatch watches Indapta Therapeutics and Innate Pharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Indapta Therapeutics and Innate Pharma — by email.

Frequently Asked Questions

Indapta Therapeutics — A biotechnology company focused on developing a natural killer cell therapy with potent ADCC activity to treat cancer.. Innate Pharma. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Indapta Therapeutics has raised $77.00M while Innate Pharma has raised $276.10M.
Indapta Therapeutics and Innate Pharma operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Indapta Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Indapta Therapeutics on 9 Jun 2026, and Innate Pharma on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy